Literature DB >> 35817840

Co-dependencies in the tumor immune microenvironment.

Peiwen Chen1, Prasenjit Dey2.   

Abstract

Activated oncogenes and disrupted tumor suppressor genes (TSGs) not only endow aspiring cancer cells with new biological capabilities but also influence the composition and function of host cells in the tumor microenvironment (TME). These non-cancer host cells can in turn provide cancer cells with growth support and protection from the anti-tumor immune response. In this ecosystem, geospatially heterogenous "subTME" adds to the complexity of the "global" TME which bestows tumors with increased tumorigenic ability and resistance to therapy. This review highlights how specific genetic alterations in cancer cells establish various symbiotic co-dependencies with surrounding host cells and details the cooperative role of the host cells in tumor biology. These essential interactions expand the repertoire of targets for the development of precision cancer treatments.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Year:  2022        PMID: 35817840     DOI: 10.1038/s41388-022-02406-7

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   8.756


  122 in total

1.  Discovery of oncogenes: The advent of molecular cancer research.

Authors:  Klaus Bister
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-07       Impact factor: 11.205

2.  DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA.

Authors:  D Stehelin; H E Varmus; J M Bishop; P K Vogt
Journal:  Nature       Date:  1976-03-11       Impact factor: 49.962

3.  The Treatment of Inoperable Sarcoma by Bacterial Toxins (the Mixed Toxins of the Streptococcus erysipelas and the Bacillus prodigiosus).

Authors:  W B Coley
Journal:  Proc R Soc Med       Date:  1910

4.  HIV-Associated Cancers and Related Diseases.

Authors:  David Zucman; François Mellot; Louis‑Jean Couderc
Journal:  N Engl J Med       Date:  2018-05-31       Impact factor: 91.245

Review 5.  Cancer immunoediting: from immunosurveillance to tumor escape.

Authors:  Gavin P Dunn; Allen T Bruce; Hiroaki Ikeda; Lloyd J Old; Robert D Schreiber
Journal:  Nat Immunol       Date:  2002-11       Impact factor: 25.606

6.  Differences between the ribonucleic acids of transforming and nontransforming avian tumor viruses.

Authors:  P H Duesberg; P K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  1970-12       Impact factor: 11.205

7.  Matrix crosslinking forces tumor progression by enhancing integrin signaling.

Authors:  Kandice R Levental; Hongmei Yu; Laura Kass; Johnathon N Lakins; Mikala Egeblad; Janine T Erler; Sheri F T Fong; Katalin Csiszar; Amato Giaccia; Wolfgang Weninger; Mitsuo Yamauchi; David L Gasser; Valerie M Weaver
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

Review 8.  The Role of Stroma in Tumor Development.

Authors:  Zena Werb; Pengfei Lu
Journal:  Cancer J       Date:  2015 Jul-Aug       Impact factor: 3.360

9.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

Review 10.  Neoantigens in cancer immunotherapy.

Authors:  Ton N Schumacher; Robert D Schreiber
Journal:  Science       Date:  2015-04-03       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.